Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
BMJ Medicine|June 18, 2025
Detection bias and the role of negative control outcomesIsaac Núñez, Anthony A Matthews
American Journal of Epidemiology|June 19, 2024
Identifying target populations to align with decision-makers' needsJennifer L Lund, Anthony A Matthews
Gut|January 22, 2024
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetesAxel Wester, Ying Shang, Emilie Toresson Grip, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 28, 2023
Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulationTyra Lagerberg, Anthony A Matthews, Nanbo Zhu, et al.
Clinical and Molecular Hepatology|July 15, 2026
Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational studyAxel Wester, Emilie Toresson Grip, Rupesh Rajani, et al.
Plos Medicine|July 21, 2025
Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trialsVanessa Voelskow, Xabier Garcia-Albeniz, Anita Berglund, et al.
European Journal of Epidemiology|May 20, 2020
Burden and prevalence of prognostic factors for severe COVID-19 in SwedenKatalin Gémes, Mats Talbäck, Karin Modig, et al.
Journal of Clinical Epidemiology|February 9, 2025
Using methods to extend inferences to specific target populations to improve the precision of subgroup analysesMichael Webster-Clark, Anthony A Matthews, Alan R Ellis, et al.
American Journal of Epidemiology|August 21, 2025
Endocrine therapies and mortality risk in postmenopausal women with breast cancer: benchmarking an observational analysis against a randomized trialAli Al-Kassab-Córdova, Anna B C Humphreys, Camila Olarte Parra, et al.
European Journal of Internal Medicine|January 22, 2025
Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIVIsaac Núñez, Yanink Caro-Vega, Conor MacDonald, et al.
Pageof 3